TrinetX Study of Hypereosinophilic Syndrome (HES) Without an Identifiable Non-haematological Secondary Cause

Clinical trial NCT06172751 · COMPLETED

Trial details

NCT number: NCT06172751
Sponsor: AstraZeneca
Status: COMPLETED
Study type: OBSERVATIONAL

Hypereosinophilic Syndrome (HES)

Start date: 2023-12-15
Primary completion: 2024-04-26
Enrollment: 250

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.